Oragenics Inc (NYSE: OGEN) — Healthcare · Share Price, Chart & Market Data
About: Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.64 (+1.74%)
OGENOragenics Inc
Loading watchlist status…
Trade OGEN now
Oragenics Inc share price
OGEN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:00 am GMT+0
OGEN price performance
-2.727%
5D
21.132%
1M
-23.571%
YTD
-88.737%
1Y
OGEN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:00 am GMT+0
OGEN details
OGEN Market Signals